Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-17 Sale | 2026-02-18 7:01 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $39.19 | $571,579 | 1,267,412 (Indirect Direct) | View |
| 2026-01-15 Sale | 2026-01-16 5:22 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 68,749 | $37.07 | $2,548,603 | 3,607,644 (Indirect Direct) | View |
| 2026-01-05 Sale | 2026-01-06 8:26 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 71,339 | $38.1 | $2,718,230 | 1,200,744 (Indirect Direct) | View |
| 2026-01-02 Sale | 2026-01-06 8:25 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 1,155 | $38.57 | $44,552 | 50,365 (Direct) | View |
| 2025-11-04 Sale | 2025-11-05 6:17 pm | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 24,520 | $18 | $441,360 | 3,955 (Direct) | View |
| 2025-10-01 Sale | 2025-10-02 7:24 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 944 | $7.8464 | $7,407 | 51,520 (Direct) | View |
| 2025-07-01 Sale | 2025-07-03 2:55 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 853 | $4.2671 | $3,640 | 52,464 (Direct) | View |
| 2025-06-27 Purchase | 2025-06-30 5:38 pm | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 10,000 | $3.9283 | $39,283 | 25,000 (Direct) | View |
| 2025-06-25 Purchase | 2025-06-25 6:08 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 23,314 | $3.8702 | $90,230 | 47,083 (Direct) | View |
| 2025-06-13 Purchase | 2025-06-16 6:05 pm | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 15,000 | $3.8055 | $57,083 | 15,000 (Direct) | View |
| 2025-04-01 Sale | 2025-04-02 6:48 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 952 | $2.4851 | $2,366 | 53,317 (Direct) | View |
| 2024-11-30 Purchase | 2025-02-03 7:28 pm | Terns Pharmaceuticals Inc. | TERN | Jung Melita Sun Chief Business Officer | 2,250 | $5.11 | $11,498 | 327,250 (Direct) | View |
| 2024-11-30 Purchase | 2025-02-03 7:25 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 510 | $5.11 | $2,606 | 1,094,609 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 7:30 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 4,481 | $5.7146 | $25,607 | 54,269 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 7:30 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 17,188 | $5.7612 | $99,024 | 74,752 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-17 Exercise | 2026-02-18 7:01 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $4.64 | 1,267,412 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 7:01 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $0 | 1,267,412 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:07 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Turner Heather D Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:07 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:06 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Azelby Robert Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:06 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:05 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:05 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 2,828 | $0 | 2,828 (Direct) | View |
| 2026-01-14 Option Award | 2026-01-16 5:24 pm | N/A 2036-01-13 | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 168,750 | $0 | 219,115 (Direct) | View |
| 2026-01-14 Option Award | 2026-01-16 5:23 pm | N/A 2036-01-13 | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 206,250 | $0 | 239,288 (Direct) | View |
| 2026-01-14 Option Award | 2026-01-16 5:22 pm | N/A 2036-01-13 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 450,000 | $0 | 3,607,644 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-16 5:22 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 41,666 | $4.64 | 3,607,644 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-16 5:22 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 68,749 | $0 | 3,607,644 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 8:26 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 21,551 | $4.64 | 1,200,744 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 8:26 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 171,551 | $0 | 1,200,744 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-05 6:17 pm | N/A 2030-12-29 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 24,520 | $0 | 3,955 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-05 6:17 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 24,520 | $9.24 | 3,955 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:44 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:44 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:43 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:43 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Turner Heather D Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:43 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:42 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-25 6:12 pm | N/A 2035-02-23 | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-24 6:05 pm | N/A 2035-02-19 | Terns Pharmaceuticals Inc. | TERN | Azelby Robert Director | 90,000 | $0 | 90,000 (Direct) | View |
Ownership | 2025-02-11 6:06 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Strauss David Eric Principal Accounting Officer | 0 | $0 | 237,173 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-03 7:37 pm | N/A 2035-01-31 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 10,657 | $0 | 10,657 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-03 7:36 pm | N/A 2035-01-31 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 10,657 | $0 | 10,657 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-03 7:35 pm | N/A 2035-01-31 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 10,657 | $0 | 10,657 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-03 7:31 pm | N/A 2035-01-31 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 10,657 | $0 | 10,657 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-03 7:30 pm | N/A 2035-01-31 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 18,650 | $0 | 18,650 (Direct) | View |
| 2025-01-30 Option Award | 2025-02-03 7:28 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Jung Melita Sun Chief Business Officer | 325,000 | $0 | 327,250 (Direct) | View |
| 2025-01-30 Option Award | 2025-02-03 7:27 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 485,000 | $0 | 485,000 (Direct) | View |
| 2025-01-30 Option Award | 2025-02-03 7:25 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 1,075,000 | $0 | 1,094,609 (Direct) | View |